NEW YORK STATE COMMON RETIREMENT FUND - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$137
-27.9%
7,358
+0.6%
0.00%
Q2 2023$190
-8.7%
7,314
+1.1%
0.00%
Q1 2023$208
-37.3%
7,237
-35.5%
0.00%
Q4 2022$332
-99.9%
11,225
-0.1%
0.00%
Q3 2022$267,000
+6.8%
11,231
+0.3%
0.00%
Q2 2022$250,000
-11.3%
11,198
-0.3%
0.00%
Q1 2022$282,000
-29.9%
11,233
+0.1%
0.00%
Q4 2021$402,000
-24.7%
11,218
-10.6%
0.00%
-100.0%
Q3 2021$534,000
-1.5%
12,546
+0.2%
0.00%0.0%
Q2 2021$542,000
+7.1%
12,517
+0.9%
0.00%0.0%
Q1 2021$506,000
-9.8%
12,4000.0%0.00%0.0%
Q4 2020$561,000
+5.1%
12,400
-17.9%
0.00%0.0%
Q3 2020$534,000
-6.3%
15,1000.0%0.00%0.0%
Q2 2020$570,000
+62.9%
15,100
+24.8%
0.00%0.0%
Q1 2020$350,000
-44.2%
12,1000.0%0.00%0.0%
Q4 2019$627,000
-17.8%
12,100
-12.9%
0.00%0.0%
Q3 2019$763,000
+34.1%
13,900
-0.7%
0.00%0.0%
Q2 2019$569,000
+34.5%
14,0000.0%0.00%0.0%
Q1 2019$423,000
-10.2%
14,0000.0%0.00%0.0%
Q4 2018$471,000
-33.9%
14,000
-17.2%
0.00%0.0%
Q3 2018$713,000
+17.3%
16,900
-11.0%
0.00%0.0%
Q2 2018$608,000
-35.6%
18,9900.0%0.00%0.0%
Q1 2018$944,000
+3.6%
18,990
+12.4%
0.00%0.0%
Q4 2017$911,000
+2.0%
16,900
+9.7%
0.00%0.0%
Q3 2017$893,000
+17.5%
15,4000.0%0.00%0.0%
Q2 2017$760,000
+13.6%
15,400
-0.0%
0.00%0.0%
Q1 2017$669,000
-24.7%
15,401
-15.1%
0.00%0.0%
Q4 2016$888,000
-69.4%
18,140
-70.0%
0.00%
-75.0%
Q3 2016$2,898,000
+6.9%
60,560
+19.9%
0.00%0.0%
Q2 2016$2,710,000
+293.3%
50,505
+228.0%
0.00%
+300.0%
Q1 2016$689,000
-66.6%
15,400
-71.5%
0.00%
-66.7%
Q4 2015$2,060,000
-47.6%
53,990
-56.3%
0.00%
-50.0%
Q3 2015$3,934,000
-15.0%
123,581
-11.8%
0.01%
-14.3%
Q2 2015$4,627,000
-5.8%
140,077
+17.4%
0.01%0.0%
Q1 2015$4,911,000
+205.0%
119,286
+201.8%
0.01%
+250.0%
Q4 2014$1,610,000
+73.7%
39,523
+56.3%
0.00%
+100.0%
Q3 2014$927,000
-70.2%
25,281
-62.3%
0.00%
-80.0%
Q2 2014$3,109,000
-46.5%
67,106
-52.5%
0.01%
-44.4%
Q1 2014$5,806,000
+86.6%
141,256
+73.3%
0.01%
+80.0%
Q4 2013$3,111,00081,5310.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders